Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT05394974
Other study ID # JOCONDE
Secondary ID
Status Recruiting
Phase
First received
Last updated
Start date June 1, 2021
Est. completion date June 1, 2023

Study information

Verified date May 2022
Source University Hospital, Strasbourg, France
Contact Mathieu ANHEIM, MD, PhD
Phone +33 3 88 12 85 35
Email mathieu.anheim@chru-strasbourg.fr
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

Joint consultations appeared a few years ago in routine medical practice, but they are still not widely used and rarely evaluated. The primary purpose of the study is to evaluate the impact for the patient of the presence of a clinical psychologist during the joint consultation. The secondary purpose is to evaluate the impact for the patient and for the neurologist of the presence of a clinical psychologist during the joint consultation


Recruitment information / eligibility

Status Recruiting
Enrollment 200
Est. completion date June 1, 2023
Est. primary completion date June 1, 2023
Accepts healthy volunteers
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria: - patient with a neurodegenerative and/or neurogenetic disease - adult patient Exclusion Criteria: - dementia - age <18 years

Study Design


Locations

Country Name City State
France Service de Neurologie - CHU de Strasbourg - France Strasbourg

Sponsors (1)

Lead Sponsor Collaborator
University Hospital, Strasbourg, France

Country where clinical trial is conducted

France, 

Outcome

Type Measure Description Time frame Safety issue
Primary Patient satisfaction after the consultation assessed by 3 questions on a Likert scale 5-point Likert scale from which to select a response :
Very satisfied.
Moderately satisfied.
Neither satisfied nor dissatisfied.
Moderately dissatisfied.
Very dissatisfied.
After consultation et 1 to 3 months later
See also
  Status Clinical Trial Phase
Terminated NCT02823158 - Bilateral Pallidal Stimulation in Patients With Advanced Parkinson's Disease-LATESTIM N/A
Recruiting NCT04926259 - Tau PET Imaging With 18F-T807(AV1451) in Neurodegenerative Disorders Early Phase 1
Withdrawn NCT02086240 - Reproducibility of the 11C-PBR28 PET Signal N/A
Active, not recruiting NCT01589809 - Effect of Nicotinamide in Friedreich's Ataxia Phase 2
Recruiting NCT04684602 - Mesenchymal Stem Cells for the Treatment of Various Chronic and Acute Conditions Phase 1/Phase 2
Completed NCT02860338 - COMPARATIVE EFFECTIVENESS OF MCI and DEMENTIA TREATMENTS IN A COMMUNITY-BASED DEMENTIA PRACTICE N/A
Recruiting NCT05639140 - A Registered Cohort Study on Color Discrimination Deficit Associated With Neurodegenerative Disorders.
Recruiting NCT00149175 - Clinical and Genetic Study of Neurodegenerative Disorders With Cognitive Impairment Phase 1
Active, not recruiting NCT00874783 - Development of iPS From Donated Somatic Cells of Patients With Neurological Diseases